Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Greenwich Lifesciences, Inc. (GLSI)  
$14.17 0.29 (2.01%) as of 4:30 Wed 9/18


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 12,750,000
Market Cap: 180.67(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.77 - $20.32
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Greenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Co.'s product candidates include GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers; and granulocyte macrophage colony-stimulating factor immunoadjuvant, which is to improve monocyte and neutrophil cytotoxicity against melanoma tumor cells and to improve activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 11,800 193,625 276,825 324,675
Total Buy Value $166,175 $2,799,883 $3,733,147 $4,328,600
Total People Bought 2 2 2 2
Total Buy Transactions 6 10 24 57
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-06-20 2024-03-19 2023-09-19 2022-09-19

   
Records found: 113
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Thompson Jaye VP Clinical Reg Affairs   •       –      –    2024-08-12 4 B $13.85 $11,080 D/D 800 263,148 2.74 6%     
   Patel Snehal CEO and CFO   •       •       •   2024-08-06 4 B $13.81 $27,620 D/D 2,000 5,534,602 3.23 -0%     
   Patel Snehal CEO and CFO   •       •       •   2024-08-05 4 B $13.18 $72,490 D/D 5,500 5,532,602 3.23 7%     
   Thompson Jaye VP Clinical Reg Affairs   •       –      –    2024-08-02 4 B $15.15 $15,150 D/D 1,000 262,348 2.74 -1%     
   Patel Snehal CEO and CFO   •       •       •   2024-07-23 4 B $15.89 $23,835 D/D 1,500 5,527,102 3.15 -12%     
   Thompson Jaye VP Clinical Reg Affairs   •       –      –    2024-07-18 4 B $16.00 $16,000 D/D 1,000 261,348 2.74 -9%     
   Patel Snehal CEO and CFO   •       •       •   2024-06-13 4 B $14.30 $2,499,998 D/D 174,825 5,525,602 3.23 -5%     
   Patel Snehal CEO and CFO   •       •       •   2024-04-01 4 B $19.08 $57,240 D/D 3,000 5,350,777 3.23 -30%     
   Patel Snehal CEO and CFO   •       •       •   2024-03-22 4 B $19.98 $49,950 D/D 2,500 5,347,777 3.23 -27%     
   Patel Snehal CEO and CFO   •       •       •   2024-03-20 4 B $17.68 $26,520 D/D 1,500 5,345,277 3.23 -12%     
   Patel Snehal CEO and CFO   •       •       •   2024-03-05 4/A B $12.49 $43,715 D/D 3,500 5,343,777 3.23     -
   Patel Snehal CEO and CFO   •       •       •   2024-03-05 4 B $12.49 $380,945 D/D 30,500 5,343,777 3.23 26%     
   Patel Snehal CEO and CFO   •       •       •   2024-03-04 4 B $13.03 $53,423 D/D 4,100 5,340,277 3.23 21%     
   Patel Snehal CEO and CFO   •       •       •   2024-02-16 4 B $11.16 $120,528 D/D 10,800 5,336,177 3.23 54%     
   Patel Snehal CEO and CFO   •       •       •   2024-02-15 4 B $11.07 $140,589 D/D 12,700 5,325,377 3.23 46%     
   Patel Snehal CEO and CFO   •       •       •   2023-11-10 4 B $10.17 $50,838 D/D 5,000 5,312,677 3.23 93%     
   Patel Snehal CEO and CFO   •       •       •   2023-11-03 4 B $9.11 $31,885 D/D 3,500 5,307,677 3.23 93%     
   Thompson Jaye VP Clinical Reg Affairs   •       –      –    2023-10-27 4 B $8.57 $4,285 D/D 500 260,348 2.66 80%     
   Patel Snehal CEO and CFO   •       •       •   2023-10-26 4 B $7.97 $19,925 D/D 2,500 5,304,177 3.15 99%     
   Patel Snehal CEO and CFO   •       •       •   2023-10-25 4 B $7.91 $19,775 D/D 2,500 5,301,677 3.15 73%     
   Patel Snehal CEO and CFO   •       •       •   2023-10-10 4 B $9.07 $9,070 D/D 1,000 5,299,177 3.15 39%     
   Patel Snehal CEO and CFO   •       •       •   2023-10-04 4 B $8.63 $17,260 D/D 2,000 5,298,177 3.15 -2%     
   Thompson Jaye VP Clinical Reg Affairs   •       –      –    2023-09-26 4 B $8.71 $5,226 D/D 600 259,848 2.74 4%     
   Patel Snehal CEO and CFO   •       •       •   2023-09-19 4 B $8.95 $35,800 D/D 4,000 5,296,177 3.23 3%     
   Patel Snehal CEO and CFO   •       •       •   2023-09-11 4 B $9.48 $9,480 D/D 1,000 5,292,177 3.15 -4%     

  113 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed